Cryptosporidiosis (Cryptosporidium spp.)

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Cryptosporidiosis is an infection caused by tiny parasites called Cryptosporidium that mainly affect the intestines. This condition leads to diarrhea, which can be watery and sometimes severe, especially in people with weakened immune systems. The parasites live in the lining of the intestines and interfere with the body's ability to absorb water and nutrients. It spreads through contaminated water or food and can cause symptoms like stomach cramps, nausea, and dehydration. The infection primarily impacts the digestive system and can last from a few days to several weeks.

Clinical Definition

Cryptosporidiosis is fecal-orally acquired infection by apicomplexan protozoa, commonly C. hominis or C. parvum. Parasites occupy an intracellular but extracytoplasmic brush-border compartment of enterocytes. Epithelial injury causes watery diarrhea and malabsorption. Disease is usually self-limited with intact immunity but can cause persistent wasting with advanced immunodeficiency.

Inciting Event

  • Ingestion of Cryptosporidium oocysts via contaminated drinking water or recreational water.

  • Consumption of food contaminated with fecal matter containing oocysts.

  • Close contact with infected persons or animals shedding infectious oocysts in stool.

  • Exposure during travel to areas with poor sanitation and contaminated water supplies.

Latency Period

  • Symptoms typically develop within 2 to 10 days after ingestion of oocysts.

  • The average incubation is about 7 days; immune suppression chiefly predicts severity and persistence rather than a reliably shorter incubation.

  • Asymptomatic shedding may occur before symptom onset, complicating transmission control.

Diagnostic Delay

  • Non-specific symptoms such as watery diarrhea are often attributed to viral or bacterial gastroenteritis.

  • Lack of routine testing for acid-fast oocysts in stool delays diagnosis.

  • Low clinical suspicion in immunocompetent patients leads to underdiagnosis.

  • Routine ova-and-parasite microscopy may miss infection without specific staining, antigen testing or molecular testing.

Clinical Presentation


Signs & Symptoms

  • Watery diarrhea usually resolves within about 2-3 weeks with intact immunity, but duration varies and symptoms may recur.

  • Abdominal cramps and nausea frequently accompany diarrhea

  • Fever is usually low-grade or absent

  • Weight loss and malabsorption in immunocompromised patients

  • Chronic diarrhea with severe dehydration in AIDS patients or other immunosuppressed individuals

History of Present Illness

  • Onset of profuse watery diarrhea often without blood or mucus, lasting days to weeks.

  • Associated symptoms include abdominal cramps, nausea, vomiting, and low-grade fever.

  • In immunocompromised patients, diarrhea is often chronic, severe, and leads to weight loss.

  • Symptoms may worsen with dehydration and electrolyte imbalances if untreated.

Past Medical History

  • History of HIV/AIDS or other causes of immunosuppression such as organ transplantation or chemotherapy.

  • Previous episodes of gastrointestinal infections or chronic diarrhea.

  • Exposure to contaminated water sources or recent travel to endemic regions.

  • Use of immunosuppressive medications such as corticosteroids or biologics.

Family History

  • No known heritable syndromes directly associated with cryptosporidiosis.

  • Family members may share exposure risks in outbreaks or contaminated water sources.

  • Household contacts with immunodeficiency may have increased susceptibility.

  • Familial clustering can occur due to shared environmental exposures.

Physical Exam Findings

  • Dehydration signs such as dry mucous membranes and decreased skin turgor due to profuse diarrhea

  • Abdominal tenderness without peritoneal signs is common

  • Fever may be present but is often low-grade or absent

  • Cachexia or weight loss in chronic or severe cases, especially in immunocompromised patients

Diagnostic Workup


Diagnostic Criteria

Confirm infection with a stool NAAT/PCR, antigen assay, or specific microscopy. Modified acid-fast microscopy may miss infection; direct fluorescent antibody testing is more sensitive. Request Cryptosporidium testing specifically if the routine panel does not include it. Repeat samples may be needed when shedding is scant or symptoms are mild.

Pathophysiology


Key Mechanisms

  • Ingestion of oocysts leads to excystation and release of sporozoites that invade intestinal epithelial cells causing villous atrophy and malabsorption.

  • Intracellular but extracytoplasmic parasitism disrupts epithelial barrier function and induces secretory diarrhea.

  • Host immune response, especially CD4+ T cells, is critical for controlling infection and limiting severity.

  • Loss of immune control permits persistent intestinal infection and sometimes biliary, pancreatic or respiratory involvement; bloodstream dissemination is not the defining mechanism.

  • Thick-walled oocysts pass in stool already infectious; thin-walled oocysts support internal autoinfection. Routine pool chlorination does not reliably eliminate them.

InvolvementDetails
Organs

Small intestine is the main organ affected, with villous atrophy and crypt hyperplasia leading to malabsorption and secretory diarrhea.

Biliary tract epithelium may be infected in advanced immunodeficiency, causing cholangitis; pancreatic or respiratory involvement can also occur.

Tissues

Intestinal mucosa is the primary site of infection where Cryptosporidium invades and disrupts epithelial integrity causing diarrhea.

Lamina propria contains immune cells that mount the host defense against the parasite.

Cells

Enterocytes are the primary host cells infected by Cryptosporidium, leading to malabsorption and diarrhea.

CD4+ T cells play a critical role in controlling infection, with depletion causing severe disease in immunocompromised hosts.

Macrophages contribute to the immune response by producing inflammatory cytokines that help contain the parasite.

Chemical Mediators

Interferon-gamma supports antiparasitic cellular immunity, including responses in infected intestinal epithelium. Do not reduce this enterocyte infection to macrophage killing.

Tumor necrosis factor-alpha promotes inflammation and helps recruit immune cells to the site of infection.

Interleukin-12 enhances the differentiation of naive T cells into Th1 cells, supporting cell-mediated immunity against the parasite.

Treatments


Pharmacological Treatments

  • Nitazoxanide

    • Mechanism:
      • Antiprotozoal action is thought to involve interference with PFOR-dependent electron transfer; the full mechanism is not established and may involve other pathways.

    • Side effects:
      • Gastrointestinal upset

      • Headache

      • Discoloration of urine

    • Clinical role:
      • Approved for cryptosporidial diarrhea in immunocompetent patients aged at least 1 year. Benefit in advanced immunodeficiency is uncertain; in HIV, a specialist may trial it alongside ART and supportive care.

  • Paromomycin

    • Mechanism:
      • Acts as an aminoglycoside antibiotic that inhibits protein synthesis in Cryptosporidium by binding to the 30S ribosomal subunit.

    • Side effects:
      • Gastrointestinal upset

      • Nephrotoxicity risk increases if intestinal injury permits systemic absorption; oral absorption is normally poor.

      • Potential aminoglycoside ototoxicity with systemic exposure; not a usual effect of poorly absorbed oral dosing.

    • Clinical role:
      • Off-label adjunct with limited evidence in HIV-associated cryptosporidiosis; it cannot replace effective ART and is not a reliably curative second-line drug.

Non-pharmacological Treatments

  • Maintain aggressive fluid and electrolyte replacement to prevent dehydration from profuse diarrhea.

  • Implement nutritional support to address malabsorption and weight loss.

  • Alongside hydration and nutrition, HIV treatment with ART is essential to restore immune control; ART is pharmacological treatment, not a supportive procedure.

Prevention


Pharmacological Prevention

  • Nitazoxanide is treatment, not recommended routine prophylaxis against cryptosporidiosis.

  • Antiretroviral therapy in HIV patients to restore immunity and prevent cryptosporidiosis

  • No widely recommended prophylactic medications for general population

Non-pharmacological Prevention

  • If water safety is uncertain, boil for at least 1 minute (3 minutes above 6,500 feet) or use a filter rated to remove Crypto, such as absolute pore size 1 micrometer or smaller.

  • Avoid swallowing recreational water. Do not swim during illness or for 2 weeks after diarrhea stops, even after treatment.

  • Wash with soap and water after toileting, diapering and animal contact and before food handling; alcohol hand sanitizer is ineffective against Crypto.

  • Proper sanitation and sewage disposal to reduce environmental contamination

  • Avoidance of high-risk exposures in immunocompromised individuals

Outcome & Complications


Complications

  • Severe dehydration leading to hypovolemic shock

  • Malabsorption syndrome causing nutritional deficiencies

  • Chronic wasting in immunocompromised hosts

  • Extraintestinal infection, especially biliary disease, can complicate severe immunodeficiency.

Short-term Sequelae Long-term Sequelae
  • Acute volume depletion requiring fluid resuscitation

  • Electrolyte disturbances such as hypokalemia

  • Transient malabsorption and weight loss

  • Temporary lactose intolerance may follow intestinal injury and worsen diarrhea. Secondary bacterial infection is not a defining routine sequela.

  • Chronic diarrhea and malnutrition in immunocompromised patients

  • Persistent infection can sustain mucosal injury and malabsorption, particularly when cellular immunity remains impaired.

  • Failure to thrive in pediatric patients with prolonged infection

  • Increased morbidity and mortality in AIDS patients without immune reconstitution

Differential Diagnoses


Cryptosporidiosis (Cryptosporidium spp.) versus Giardiasis

Cryptosporidiosis (Cryptosporidium spp.)

Giardiasis

Exposure to contaminated water or immunocompromised status, especially HIV infection

Ingestion of contaminated freshwater or exposure to daycare settings

Apicomplexan protozoan Cryptosporidium spp.

Flagellated protozoan Giardia lamblia

Acid-fast staining or immunofluorescence of oocysts in stool

Detection of cysts or trophozoites in stool by microscopy or antigen testing

Watery diarrhea with possible severe dehydration, especially in immunocompromised

Often causes malabsorption with greasy, foul-smelling diarrhea

Cryptosporidiosis (Cryptosporidium spp.) versus Cystoisosporiasis (formerly isosporiasis)

Cryptosporidiosis (Cryptosporidium spp.)

Cystoisosporiasis (formerly isosporiasis)

Occurs across immune states; advanced immunodeficiency increases severity

Also occurs with intact immunity; severe or recurrent infection is particularly important in AIDS

Apicomplexan coccidian Cryptosporidium species

Apicomplexan coccidian Cystoisospora belli, formerly Isospora belli

Small round oocysts, about 4-6 micrometers

Much larger ellipsoid oocysts, about 25-30 micrometers long; eosinophilia may occur

Supportive care, selected nitazoxanide, and ART when HIV-associated; TMP-SMX is not recommended therapy

TMP-SMX is preferred treatment; immunocompromised patients may need prolonged treatment and secondary prophylaxis

Cryptosporidiosis (Cryptosporidium spp.) versus Cyclospora infection

Cryptosporidiosis (Cryptosporidium spp.)

Cyclospora infection

Oocysts are immediately infectious, enabling direct person-to-person transmission

Oocysts require environmental sporulation; contaminated produce or water is typical, and immediate direct transmission is unlikely

Coccidian parasite Cryptosporidium spp.

Coccidian parasite Cyclospora cayetanensis

Small round oocysts, approximately 4-6 micrometers; use specific stains, antigen or NAAT testing

Larger round oocysts, approximately 8-10 micrometers, with UV autofluorescence and variable acid-fast staining

Self-limited watery diarrhea in immunocompetent; severe in immunocompromised

Prolonged relapsing diarrhea in immunocompetent hosts

Cryptosporidiosis (Cryptosporidium spp.) versus Microsporidiosis

Cryptosporidiosis (Cryptosporidium spp.)

Microsporidiosis

Affects both immunocompetent and immunocompromised but more severe in latter

Primarily affects severely immunocompromised patients, especially AIDS

Intracellular protozoan parasite Cryptosporidium spp.

Obligate intracellular spore-forming fungi Microsporidia

Oocysts detected by acid-fast stain or immunofluorescence

Spores detected by modified trichrome stain or electron microscopy

Primarily gastrointestinal symptoms with watery diarrhea

Chronic diarrhea with possible systemic involvement

Cryptosporidiosis (Cryptosporidium spp.) versus Clostridioides difficile colitis

Cryptosporidiosis (Cryptosporidium spp.)

Clostridioides difficile colitis

Exposure to contaminated water or immunosuppression

Recent antibiotic use or hospitalization

Watery diarrhea without pseudomembranes, often milder in immunocompetent

Profuse watery diarrhea with abdominal pain and possible pseudomembranous colitis

Stool Cryptosporidium-specific microscopy, antigen or NAAT testing

Test compatible diarrheal illness with an appropriate toxin/NAAT algorithm; a positive organism test can reflect colonization